Metagenomi Patents – Insights & Stats (Updated 2025)

Metagenomi has a total of 343 patents globally, out of which 25 have been granted. Of these 343 patents, more than 88% patents are active. United States of America is where Metagenomi has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Metagenomi.

Founded in 2018, Metagenomi is a precision genetic medicines company developing curative therapies using its proprietary genome editing toolbox derived from metagenomics. By exploring genetic material from uncultivated organisms, Metagenomi is creating next-generation editing tools capable of making precise therapeutic edits anywhere in the human genome.

Do read about some of the most popular patents of Metagenomi which have been covered by us in this article and also you can find Metagenomi patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Metagenomi patent portfolio.

How many patents does Metagenomi have?

Metagenomi has a total of 343 patents globally. These patents belong to 51 unique patent families. Out of 343 patents, 303 patents are active.

How Many Patents did Metagenomi File Every Year?

Metagenomi Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantMetagenomi Applications FiledMetagenomi Patents Granted
202533
20246114
2023926
2022109
2021642
202014

How many Metagenomi patents are Alive/Dead?

Worldwide Patents

Metagenomi Patent Portfolio


How Many Patents did Metagenomi File in Different Countries?

Metagenomi Worldwide Patent Filing Trend

Countries in which Metagenomi Filed Patents

CountryPatents
United States of America35
Europe (EPO)31
China30
Korea (South)28
Australia27
Japan25
India24
Mexico24
Canada21
Hong Kong (S.A.R.)21
Brazil19
United Kingdom11

Where are Research Centres of Metagenomi Patents Located?

All Research center of Metagenomi are in the United States of America.

10 Best Metagenomi Patents

WO2021202568A1 is the most popular patent in the Metagenomi portfolio. It has received 11 citations so far from companies like Sigma-Aldrich & Editas Medicine.

Below is the list of 10 most cited patents of Metagenomi:

Publication NumberCitation Count
WO2021202568A111
WO2023039378A18
WO2022056324A18
WO2021178934A18
WO2022159758A17
US10913941B26
WO2021202559A16
WO2023097282A15
WO2022198080A15
WO2023081855A14

What Percentage of Metagenomi US Patent Applications were Granted?

Metagenomi (Excluding its subsidiaries) has filed 33 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 85.71%.

Below are the key stats of Metagenomi patent prosecution at the USPTO.

Which Law Firms are managing US Patents for Metagenomi?

Law FirmTotal ApplicationsSuccess Rate
Metagenomi (Inhouse IP Dept.)3185.71%
Goodwin Procter Llp10%
Wilson Sonsini Goodrich & Rosati10%

What are Metagenomi key innovation segments?

What Technologies are Covered by Metagenomi?

The chart below distributes patents filed by Metagenomi in different countries on the basis of the technology protected in patents. It also represents the markets where Metagenomi thinks it’s important to protect particular technological inventions.

R&D Focus: How has Metagenomi search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Metagenomi?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.